Lindsay Lohr
Global A2R Strategy Finance Director, Johnson & Johnson
Professional Overview
Lindsay Lohr is an accomplished finance executive with over 15 years of experience in the pharmaceutical industry. As the Global A2R Strategy Finance Director at Johnson & Johnson, she plays a pivotal role in shaping the company's strategic financial initiatives and driving operational excellence across the organization.
Experience Summary
Current Role
In her current position, Lindsay is responsible for overseeing the financial strategy and performance of Johnson & Johnson's global A2R (Acquire-to-Retire) operations. She collaborates closely with cross-functional leaders to identify opportunities for cost optimization, process improvements, and revenue growth. Under her leadership, the A2R team has achieved significant cost savings and operational efficiencies, contributing to the company's overall financial performance.
Career Progression
Prior to her current role, Lindsay held various finance leadership positions within Johnson & Johnson's Janssen Pharmaceutical Companies and Ethicon divisions. She has demonstrated a track record of driving strategic initiatives, enhancing financial controls, and building high-performing teams. Her progressive career growth within the organization is a testament to her exceptional analytical skills, business acumen, and ability to navigate complex financial environments.
Academic Background
Lindsay holds a Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign, where she graduated with honors. She is also a Certified Public Accountant (CPA), further strengthening her technical expertise in financial reporting and analysis.
Areas of Expertise
- Strategic financial planning and analysis
- Cost optimization and process improvement
- Financial reporting and control systems
- Cross-functional collaboration and stakeholder management
- Team leadership and development
Professional Impact
Through her leadership, Lindsay has significantly contributed to the financial performance and operational efficiency of Johnson & Johnson's global operations. She has spearheaded initiatives that have resulted in multimillion-dollar cost savings, improved inventory management, and enhanced financial visibility across the organization. Her expertise and innovative approach have been recognized by her peers and have solidified her reputation as a strategic finance leader within the pharmaceutical industry.
Conclusion
With her extensive experience, strong analytical skills, and proven track record of success, Lindsay Lohr is a valuable asset to Johnson & Johnson. As the Global A2R Strategy Finance Director, she continues to drive financial excellence, operational optimization, and strategic decision-making to support the company's long-term growth and profitability.
